Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework

Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Couillard, S, Pavord, I, Heaney, L, Petousi, N, Hinks, T
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Wiley 2022

Παρόμοια τεκμήρια

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
ανά: Couillard, S, κ.ά.
Έκδοση: (2021)

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
ανά: Couillard, S, κ.ά.
Έκδοση: (2021)

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
ανά: Couillard, S, κ.ά.
Έκδοση: (2022)

Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
ανά: Couillard, S, κ.ά.
Έκδοση: (2020)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
ανά: Rastogi, S, κ.ά.
Έκδοση: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
ανά: Moran, AM, κ.ά.
Έκδοση: (2020)

Eosinophilic phenotypes of airway disease.
ανά: Pavord, I
Έκδοση: (2013)

Prognostic value of using FeNO to guide step-down treatment decisions in asthma
ανά: Wang, K, κ.ά.
Έκδοση: (2018)

Eosinophils in asthma and airway hyperresponsiveness.
ανά: Brightling, C, κ.ά.
Έκδοση: (2004)

FeNO-based asthma management results in faster improvement of airway hyperresponsiveness
ανά: Katrine Feldballe Bernholm, κ.ά.
Έκδοση: (2018-10-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
ανά: Connolly, CM, κ.ά.
Έκδοση: (2017)

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
ανά: Couillard, S, κ.ά.
Έκδοση: (2021)

Exhaled Nitric Oxide (FeNO) as a Non-Invasive Marker of Airway Inflammation
ανά: Mitsuru Munakata
Έκδοση: (2012-01-01)

The Pitfalls of FeNO Testing
ανά: Sujoy Khan
Έκδοση: (2013-01-01)

The Lancet COPD Commission: broader questions remain
ανά: Petousi, N, κ.ά.
Έκδοση: (2023)

The significance of eosinophilic airway inflammation in asthma
ανά: Pavord, I, κ.ά.
Έκδοση: (2002)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
ανά: Moran, A, κ.ά.
Έκδοση: (2020)

Toward a predict and prevent approach in obstructive airway diseases
ανά: Couillard, S, κ.ά.
Έκδοση: (2023)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2003)

The making of the atomic bomb /
ανά: 435392 Rhodes, Richard
Έκδοση: (1986)

Prognostic value of FeNO-guided assessment to identify steroid-responsive respiratory symptoms
ανά: Wang, K, κ.ά.
Έκδοση: (2018)

Association Between FeNO, Total Blood IgE, Peripheral Blood Eosinophil and Inflammatory Cytokines in Partly Controlled Asthma
ανά: Badar A, κ.ά.
Έκδοση: (2020-10-01)

Current evidence and future research needs for FeNO measurement in respiratory diseases
ανά: Bjermer, L, κ.ά.
Έκδοση: (2014)

Current evidence and future research needs for FeNO measurement in respiratory diseases.
ανά: Bjermer, L, κ.ά.
Έκδοση: (2014)

Update on the Role of FeNO in Asthma Management
ανά: Neveda Murugesan, κ.ά.
Έκδοση: (2023-04-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
ανά: Brightling, C, κ.ά.
Έκδοση: (2000)

Association of general and abdominal obesity with lung function, FeNO, and blood eosinophils in adult asthmatics: Findings from NHANES 2007–2012
ανά: Haoyu Zhang, κ.ά.
Έκδοση: (2023-02-01)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
ανά: Brightling, C, κ.ά.
Έκδοση: (2004)

What is the added value of FeNO as T2 biomarker?
ανά: María Celeste Marcos, κ.ά.
Έκδοση: (2022-08-01)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
ανά: Kulkarni, N, κ.ά.
Έκδοση: (2010)

Exposure to organophosphate flame retardants and plasticizers is positively associated with wheeze and FeNO and eosinophil levels among school-aged children: The Hokkaido study
ανά: Yi Zeng, κ.ά.
Έκδοση: (2023-11-01)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
ανά: Lavoie, G, κ.ά.
Έκδοση: (2024)

Measuring lung function in airways diseases: current and emerging techniques
ανά: Petousi, N, κ.ά.
Έκδοση: (2019)

Dark sun : the making of the hydrogen bomb /
ανά: 435392 Rhodes, Richard
Έκδοση: (1995)

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease
ανά: Petousi, N, κ.ά.
Έκδοση: (2024)

IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma
ανά: Jorge Sánchez, κ.ά.
Έκδοση: (2021-03-01)

The change of FeNO is correlated with asthma control and lung function
ανά: Yanmin Gao, κ.ά.
Έκδοση: (2024-10-01)

FeNO as a biomarker for airway inflammation due to exposure to air pollutants among school children nearby industrial areas in Terengganu
ανά: Kamaruddin, Anis Syafiqah, κ.ά.
Έκδοση: (2019)

Blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO) for steroid stewardship in chronic obstructive pulmonary disorder (COPD): A systematic review
ανά: Aditi Dhawan, κ.ά.
Έκδοση: (2024-09-01)

Nasal Airflow Measured by Rhinomanometry Correlates with FeNO in Children with Asthma.
ανά: I-Chen Chen, κ.ά.
Έκδοση: (2016-01-01)